Testing Experimental Parkinson's Disease Medication
common.study.values.description
“Lu AF82422 in Healthy Non-Japanese and Japanese Subjects and in Patients With Parkinson's Disease”
The purpose of this study is to investigate the safety of a single dose of Lu AF82422, how well it is tolerated, how the drug effects the body and what the body does to the drug in healthy non-Japanese and Japanese subjects and in patients with Parkinson's disease
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - Lu AF82422
Lu AF82422 - concentrate for solution for infusion; vials containing 50mg/ml, single dose
Drug - Placebo
placebo - concentrate for solution for infusion, single dose
participant.views.study.view.additional
participant.views.study.view.scientific-title
Interventional, Randomized, Double-blind, Sequential-group, Placebo-controlled, Single-ascending-dose Study Investigating the Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Properties of Lu AF82422 in Healthy Non-Japanese and Japanese Subjects and in Patients With Parkinson's Disease
common.study.values.clinical-trial-id
NCT03611569
participant.views.study.view.id
b4x8Vb
